-
Product Insights
Acute Heart Failure – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Heart Failure - Drugs In Development, 2023’, provides an overview of the Acute Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Heart Failure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Company Profile
Altamira Therapeutics Ltd – Company Profile
Altamira Therapeutics Ltd (Altamira Therapeutics) formerly Auris Medical Holding Ltd, is a clinical-stage biopharmaceutical company with a focus on neurotology and CNS disorders. The company’s pipeline product candidates are in various clinical phases intended for the treatment of acute inner ear tinnitus, post-acute inner ear tinnitus, Vertigo, tinnitus, sudden loss of hearing, antipsychotic-induced weight gain, somnolence, airborne allergens and viruses. It has research collaboration and licensing agreements with Biotechnology companies including Xigen and Inserm. Auris Medical is headquartered in Hamilton,...
Add to Basket -
Product Insights
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prostate cancer usually occurs in older men. Its symptoms include problems while urinating, decreased force in the stream of urine, blood in the urine, pain in the lower back, hips, or thighs, bone pain, and erectile dysfunction. The Prostate Cancer pipeline market research report provides comprehensive information on the therapeutics under development for Prostate Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the...
-
Product Insights
Prader-Willi Syndrome (PWS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prader-Willi Syndrome (PWS) is a rare genetic disorder present at birth that results in several physical, mental, and behavioral problems. PWS is due to the lack of several genes on one of an individual’s two chromosome 15s. In most cases, there is a deletion. In remaining cases, the entire chromosome from the father is missing and there are instead two chromosome 15s from the mother (uniparental disomy). Symptoms include poor muscle tone, low levels of sex hormones, and a constant...
-
Product Insights
Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Congestive heart failure (heart failure) report provides comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Congestive Heart Failure...